期刊文献+

肝硬化超声造影时相变化的实验性研究

Experimental research on contrast-enhanced ultrasound phase changes in rabbits with liver cirrhosis
下载PDF
导出
摘要 目的观察兔肝硬化模型超声造影时相变化,探讨超声造影评价肝硬化血流动力学变化的应用价值。方法选择雄性新西兰兔30只,分为实验组和对照组,实验组建立肝硬化动物模型,采用团注法注射声学造影剂声诺维,应用低机械指数实时双幅超声造影及时间-强度曲线,定量分析两组超声造影肝实质造影剂始增时间、峰值强度、峰值强度减半时间。结果病理显示:实验组呈肝硬化改变,对照组为正常肝组织。超声造影时间-强度曲线显示:肝实质造影剂开始增强时间两组分别为:(6.79±1.08)s、(3.46±1.27)s,实验组明显长于对照组;造影剂峰值强度两组分别为:(73.91±10.31)dB、(159.12±12.24)dB,实验组明显小于对照组;造影剂峰值强度减半时间明两组分别为:(15.97±9.48)s、(56.58±13.85)s,实验组明显小于对照组,差异均有统计学意义(t分别=7.47、19.92、8.96,P均<0.05)。结论肝硬化时肝实质与正常肝实质超声造影时相有显著差异,超声造影对评定肝硬化血流动力学变化有重要参考价值。 Objective To probe the value of contrast-enhanced ultrasound(CEUS) in evaluating the hemodynamic changes in rabbits with liver cirrhosis by analyzing the CEUS phase changes.Methods Thirty male New Zealand rabbits were grouped into A group and B group to build control group and liver cirrhosis model group,respectively.CEUS examinations were performed 10 weeks later by bonus injecting contrast agent SonoVue.CEUS time-intensity curve was used to acquire the contrast arrival time(AT) of the liver parenchyma,peak intensity(PI) and the half-intensity reduced time(HIRT) of the above groups.Results Liver contrast agent started to time A,B group,respectively:(6.79 ± 1.08) s,(3.46 ± 1.27)s,A group was significantly longer than that of group B;contrast agent peak intensity A,B groups were:(73.91±10.31) dB,(159.12±12.24)dB,A group was significantly less than that of group B;half-time peak intensity of contrast agent that A,B groups were:(15.97±9.48)s,(56.58±13.85)s,A group significantly less than that of group B;the differences were statistically significant(t=7.47,19.92,8.96,P〈0.05).Conclusions CEUS is valuable to evaluate the hemodynamic changes of liver cirrhosis.
作者 刘燕萍
出处 《全科医学临床与教育》 2011年第4期407-408,417,F0003,共4页 Clinical Education of General Practice
关键词 超声造影 肝硬化 造影时相 血流动力学 contrast-enhanced ultrasound liver cirrhosis contrast phase hemodynamic
  • 相关文献

参考文献9

  • 1纪凤颖,徐克,范金玉.兔早期肝硬化形成中CT灌注成像的实验研究[J].中国医学影像技术,2007,23(5):645-648. 被引量:3
  • 2王晓艳,林礼务,薛恩生,何以敉,高上达,俞丽云.超声造影与流速剖面技术评价肝硬化程度的临床意义[J].中华超声影像学杂志,2006,15(11):809-812. 被引量:12
  • 3华兴,李锐,郭燕丽,张萍,郭爱民.声学造影后肝硬化大鼠肝脏声像图分析的动态研究[J].中国临床医学影像杂志,2006,17(9):523-525. 被引量:4
  • 4尹珊珊,严昆,戴莹,武金玉,陈敏华.实时灰阶超声造影对肝硬化定量诊断的初步探讨[J].中国医学影像技术,2004,20(5):731-733. 被引量:25
  • 5Albrecht T,Blomley MJ,Cosgrove DO,et al.Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet,The . 1999
  • 6Kleber G,Steudel N,Behrmann C,et al.Hepatic arterial flow volume and reserve in patients with cirrhosis: use ofintra-arterial Doppler and adenosine infusion. Gastroenterology . 1999
  • 7Leen E,Goldberg JA,Anderson JR,et al.Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut . 1993
  • 8Bokor D,Chambers J B,Rees P J,et al.Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Investigative Radiology . 2001
  • 9Luo W,Zhou X,Ren X,et al.Enhancing effects of SonoVue,a mi-crobbule sonographic contrast agent,on high-intensity focused ul-trasound ablation in rabbit livers in vivo. Ultrasound in Medicine and Biology . 2007

二级参考文献36

  • 1范光明,郭启勇,解学乾,陈丽英,于涛,侯阳.造影剂量和注射流率对肝脏CT灌注成像影响的实验研究[J].中国医学影像技术,2005,21(1):14-17. 被引量:14
  • 2管生,赵卫东,周康荣,彭伟军,毛健,唐峰,王勇,曹光,孙非.肝炎、肝纤维化和早期肝硬化阶段肝脏CT灌注实验动物的初步研究[J].中华放射学杂志,2005,39(8):877-881. 被引量:28
  • 3隋建超.肝硬化时全身血液动力学改变[J].临床内科杂志,1995,12(2):12-13. 被引量:8
  • 4华兴,李锐,郭艳丽,张萍,郭爱民.邻接点算法结合SonoCT技术分析肝硬化声像图纹理的实验研究[J].中华超声影像学杂志,2006,15(2):132-134. 被引量:1
  • 5叶任高.内科学(第5版)[M].北京:人民卫生出版社,2000.159.
  • 6[1]Gaiani S,Gramantieri L,Venturoli N,et al.What is the criterion of differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy[J].J Hepatol,1997,27(6):979-985.
  • 7[2]Khan KN,Yamasaki M,Yamasaki K,et al.Proposed abdominal sonographic staging to predict severity of liver diseases:analysis with peritoneoscopy and histology[J].Dig Dis Sci,2000,45(3):554-564.
  • 8[3]Zoli M,Magalotti D,Bianchi G,et al.Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis[J].J Hepatol,1995,23(2):129-134.
  • 9[4]Albrecht T,Blomley MJ,Cosgrove DO,et al.Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent[J].Lancet,1999,353(9164):1579-1583.
  • 10[5]Sanford NL,Walsh P,Matis C,et al.Is ultrasonography useful in the assessment of diffuse parenchymal liver disease[J]? Gastroenterology,1985,89(1):186-191.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部